Pilot Evaluation: Toronto Heart Centre to conduct comparative testing of CardioYield™ for enhanced Holter ECG analysis and reporting efficiency. Clinical Workflow Impact: Study to measure time savings, throughput improvements, and analysis quality when using CardioYield™ versus current industry-standard software. TORONTO, ON, AB / ACCESS Newswire / October 7, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)... Read More

Leveraging MaxYield™ ECG to capture real-world exercise data in people living with neurological conditions Generating actionable insights into how cardiac responses may correlate with brain health and outcomes TORONTO, ON / ACCESS Newswire / September 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leader in AI-powered signal interpretation, is pleased to announce a pilot... Read More

VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / AI/ML Innovations Inc . (" AIML " or the " Company ") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce that Company completed its previously announced non-brokered private placement offering on September 4, 2025 on an oversubscribed basis. On September 4, 2025, the Company announced a proposed private placement of up to 31,000,000 units (" Units ") at a price... Read More

VANCOUVER, BC / ACCESS Newswire / September 4, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it intends to complete a non-brokered private placement offering of up to 31,000,000 units (" Units ") at a price of $0.05 per Unit for gross proceeds of up to $1,550,000 (" Private Placement "). Each Unit is comprised of one Common Share and one warrant which... Read More

VANCOUVER, BC / ACCESS Newswire / August 21, 2025 / AI/ML Innovations Inc . (" AIML " or the " Company ") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is issuing the following press release to clarify its disclosure as a result of a review by the British Columbia Securities Commission. The Company announces today that it has filed an amended and restated management's discussion and analysis for the three and nine month periods ended... Read More

VANCOUVER, BC / ACCESS Newswire / August 8, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB: 42FB) is pleased to confirm it has closed its previously announced restructuring ("Restructuring") of the terms and conditions associated with its previously completed acquisition of the outstanding common shares of Quantum Sciences Ltd. ("Quantum"). The Quantum acquisition was originally closed... Read More

Neural Cloud Solutions, an AIML subsidiary, files broad provisional patent applications covering advanced neural network architectures and cloud‑based ECG signal optimization workflows Filings enhance the scope of AIML's device‑agnostic ECG enhancement platform, supporting global commercialization strategy VANCOUVER, BC / ACCESS Newswire / June 10, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)... Read More

Letter of Intent: Circular Health Limited to Enhance ECG Smart Ring with AI-Powered Signal Clarity with multi‑year, per‑user SaaS license targeting commercial launch by September 2025. Global growth catalyst: The collaboration positions both companies to scale AI‑enhanced cardiac monitoring and next-gen health intelligence across new geographies and device form factors. Economic and Clinical Benefits: MaxYield(TM) is... Read More

New board‑level committee will steer regulatory strategy, IP development, and product innovation across AIML's AI‑driven health‑tech portfolio TORONTO, ON / ACCESS Newswire / May 22, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) today announced the formation of its Innovation Committee , a committee of the Board of Directors of AIML, created to provide strategic oversight of the... Read More

Medical Advisory Board will guide clinical studies, regulatory strategy, and global adoption of AIML's AI‑driven ECG signal‑processing solutions MaxYield™ and CardioYield™ across wearables and cardiology workflows. AIML simultaneously debuts its redesigned corporate website, AIML.Health , offering an interactive hub for investors, partners, and stakeholders. TORONTO, ON / ACCESS Newswire / May 20, 2025 / AI/ML Innovations... Read More

Proprietary neural network, cloud-based AI-powered technology designed to support clearer ECG signal interpretation across care settings. TORONTO, ON / ACCESS Newswire / May 15, 2025 / AI/ML Innovations Inc . (" AIML " or the " Company ") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a developer of AI-based signal processing technologies for healthcare, today announced it has submitted a 510(k) premarket notification to the U.S. Food... Read More

Appointment brings public policy expertise, strategic insight, and business development acumen as AIML accelerates global AI healthcare deployment. VANCOUVER, BC / ACCESS Newswire / May 5, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce the appointment of Michael Diamond to its Board of Directors (" Board "), effective immediately. Mr. Diamond is ​a ​... Read More

• Tim Daniels to Continue Supporting AIML in an Advisory Capacity VANCOUVER, BC / ACCESS Newswire / April 25, 2025 / AI/ML INNOVATIONS INC. ("AIML" OR THE "COMPANY") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) announces that Tim Daniels has stepped down from his position on the Company's Board of Directors (" Board "), effective immediately. Tim has been an integral part of AIML's leadership, contributing to the Company's strategic... Read More

Restructured agreement increases capital efficiency, simplifies revenue structure, and expands future opportunity. VANCOUVER, BC / ACCESS Newswire / April 25, 2025 / AI/ML Innovations Inc . (" AIML " or the " Company ") (CSE:AIM) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce that it has entered into an agreement dated April 11, 2025 (the " Restructuring Agreement ") setting forth certain revised terms and conditions in... Read More

VANCOUVER, BC / ACCESS Newswire / April 22, 2025 / AI/ML Innovations Inc . (" AIML " or the " Company ") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the appointment of Jared Adelstein to its Board of Directors (" Board "), effective immediately. This appointment is part of AIML's broader effort to strengthen its leadership team as the Company enters an exciting phase of strategic growth and commercialization in... Read More

VANCOUVER, BC / ACCESS Newswire / April 15, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce that Company completed its previously announced non-brokered private placement offering on April 15, 2025 on an oversubscribed basis. On April 7, 2025, the Company announced a proposed private placement of up to 40,000,000 units (" Units ") at a price of $0.05 per... Read More

VANCOUVER, BC / ACCESS Newswire / April 7, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce that it intends to complete a non-brokered private placement offering of up to 40,000,000 units (" Units ") at a price of $0.05 per Unit for gross proceeds of up to $2,000,000 (" Private Placement "). Each Unit is comprised of one Common Share and one warrant which... Read More

VANCOUVER, BC / ACCESS Newswire / April 4, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce that it intends to complete a non-brokered private placement offering of up to 40,000,000 units (" Units ") at a price of $0.05 per Unit for gross proceeds of up to $2,000,000 (" Private Placement "). Each Unit is comprised of one Common Share and one warrant which... Read More

AIML Sharpens Focus with Strategic Exit from Tech2Heal Aligning Resources for Commercialization and Core Portfolio Growth Transition Positions AIML to Prioritize Commercial Execution While Remaining Open to Future Collaboration VANCOUVER, BC / ACCESS Newswire / March 21, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the execution of a formal exit agreement... Read More

Paul Duffy Appointed Executive Chairman of the Board Peter Kendall Joins Board Seasoned Advisors Mark Orsmond and Michael Nemirow to Support AIML's Corporate Development Initiatives VANCOUVER, BC / ACCESS Newswire / March 14, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce key updates to its Board of Directors (" Board ") as the Company enters an exciting new... Read More

VANCOUVER, BC / ACCESS Newswire / February 21, 2025 / AI/ML Innovations Inc . (" AIML " or the " Company ") (CSE:AIML) (OTCQB:AIMLF)(FWB:42FB) is pleased to announce voting results from the Company's Annual General and Special Meeting of shareholders held earlier in the day in virtual-only format (" AGM "). The matters voted upon were outlined in the Company's Management Information Circular dated January 9, 2025 (" Circular... Read More

The number of board seats to be set at four, making room for an additional independent director Drew Dundas nominated to AI/ML Innovations Board of Directors VANCOUVER, BC / ACCESS Newswire / February 20, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to provide important updates regarding its upcoming annual general and special meeting scheduled for February 21, 2025... Read More

▪ Accomplished Leader to Oversee Quality and Compliance Across AIML's Global Operations ▪ Strengthens AIML's Commitment to Providing Reliable and Innovative AI-Powered Healthcare Solutions VANCOUVER, BC / ACCESS Newswire / February 5, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce the appointment of Andrea L. Ruth, M.S., as Head of Quality, Clinical, and... Read More

Cardiologist and Visionary Joins Executive Leadership Team Reinforces Commitment to Cutting-Edge Digital Healthcare Solutions VANCOUVER, BC / ACCESS Newswire / January 27, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce the appointment of Dr. Alan Rabinowitz, a globally recognized leader in cardiology and healthcare innovation, as Chief Medical Officer (CMO)... Read More

Mark Orsmond , a highly respected business professional in Canadian Healthcare, Appointed Executive Chair Michael Nemirow Joins as Director, Bringing Decades of Entrepreneurial Expertise VANCOUVER, BC / ACCESSWIRE / January 9, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies... Read More

Accomplished Commercialization Leader to Drive Global Growth . Proven Expertise in Scaling Health Tech Businesses - Mr. Kendall Brings a Track Record of Success Leading High-Performing Teams Across Canada, the US, and Europe. Strategic Leadership to Propel Expansion - New Appointment Signals AIML's Commitment to Transforming Healthcare Through Global Market Success. VICTORIA, BC / ACCESSWIRE / January 6, 2025 / AI/ML... Read More

Strategic Expansion into Cardio AI-Driven Healthcare Solutions Collaboration to Enhance Patient-Centered Digital Healthcare Technologies Welcomes Key Industry Experts to Drive Innovation VICTORIA, BC / ACCESSWIRE / December 24, 2024 / AI/ML Innovations Inc . (the " Company " or " AI/ML ") (CSE:AIML)(OTCQB:AIMLF) (FWB:42FB) is pleased to announce that it has closed the arms-length share purchase previously announced on... Read More

VICTORIA, BC / ACCESSWIRE / December 11, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to report that it has completed its previously announced shares for debt transaction. Further to a press release issued on December 3,... Read More

VICTORIA, BC / ACCESSWIRE / December 10, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it has entered into an arms-length share purchase agreement dated December 9, 2024 (the " SPA ") to acquire all of the issued and outstanding shares (the " Acquisition ") of Quantum Sciences Ltd. (" Quantum "). Quantum currently carries on the business of designing... Read More

VICTORIA, BC / ACCESSWIRE / December 3, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to report that, effective immediately, it has appointed Terence Lee as Chief Financial Officer. Terence is Chartered Professional... Read More

VICTORIA, BC / ACCESSWIRE / November 27, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that it has re-appointed Follow The Money Investment Group ("FTMIG") as a marketing consultant. FTMIG is a marketing group... Read More

VICTORIA, BC / ACCESSWIRE / November 26, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce that that it has completed its previously announced non-brokered private placement of units (the "Units") on November 26, 2024 (the "Financing"). The Company accepted subscriptions on this final tranche of 24,500,615 Units at a price of $0.065 per Unit, for gross... Read More

VICTORIA, BC / ACCESSWIRE / November 1, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) announces that that it has completed its initial closing of its previously announced (October 21, 2024) non-brokered private placement by the issue of 19,688,461 Shares and Warrants for gross proceeds of $1,279,750. Finders fees of $44,070 and 504,000 broker warrants having the same terms as... Read More

VICTORIA, BC / ACCESSWIRE / October 28, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) announces that, further to its press release dated October 21, 2024, the Company has received exchange approval to increase the proposed non-brokered private placement offering from the previously announced 20,000,000 units up to 40,000,000 units ("Units"). Each Unit remains priced at $0.065,... Read More

Up to 20,000,000 Units to be Issued at $0.065 per Unit VICTORIA, BC / ACCESSWIRE / October 21, 2024 / AI/ML Innovations Inc. (" AI/ML " or the " Company ") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce that that it intends to complete a non-brokered private placement offering of up to 20,000,000 units (" Units ") at a price of $0.065 per Unit for gross proceeds of up to $1,300,000 (the " Private Placement ").... Read More

VICTORIA, BC / ACCESSWIRE / October 11, 2024 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, reports that effective immediately, Randy Duguay has resigned from the Board of Directors so that he may focus his full attention to his duties at... Read More

VICTORIA, BC / ACCESSWIRE / October 10, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) announces that, as disclosed in its recently filed financial statements, the Company performed an assessment of indicators of impairment in the investment in its minority-owned subsidiary, Tech2Heal, and recorded an impairment loss of $1,510,668 as a result of the outcome of the assessment. The... Read More

VICTORIA, BC / ACCESSWIRE / October 2, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that the Company's principal regulator, the British Columbia Securities Commission (" BCSC ") has lifted the Management Cease Trade Order (" MCTO ") it had previously granted the Company on August 29, 2024 under National Policy 12-203 Management Cease Trade Orders (" NP... Read More

TORONTO, ON / ACCESSWIRE / September 20, 2024 / AI/ML Innovations Inc. (the " Company ") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) announces that further to its news releases dated August 23, 2024, August 29, 2024 and September 6, 2024, the Company's principal regulator, the British Columbia Securities Commission (the " BCSC "), granted a management cease trade order (the " MCTO ") on August 29, 2024 under National Policy 12-203... Read More

VICTORIA, BC / ACCESSWIRE / September 6, 2024 / AI/ML Innovations Inc. (the " Company ") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) announces that further to its news releases dated August 23, 2024 and August 29, 2024, the Company's principal regulator, the British Columbia Securities Commission (the " BCSC "), granted a management cease trade order (the " MCTO ") on August 29, 2024 under National Policy 12-203 Management Cease... Read More

VICTORIA, BC / ACCESSWIRE / August 29, 2024 / AI/ML Innovations Inc. (the " Company ") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, did not file its audited annual financial statements, management's discussion and analysis and related CEO and CFO certifications for the financial year ended April... Read More

VICTORIA, BC / ACCESSWIRE / August 23, 2024 / AI/ML Innovations Inc. (the " Company ") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that it has made an application to the British Columbia Securities Commission (" BCSC ") to approve a management case trade order (" MCTO ") under National Policy 12-203 Management Cease Trade Orders (" NP 12-203 "), which, if granted, will prohibit trading in the securities of the Company by the... Read More

VICTORIA, BC / ACCESSWIRE / August 23, 2024 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that it has closed its previously announced acquisition of technology from Naiad Lab Inc. The Company issued a total of... Read More

VICTORIA, BC / ACCESSWIRE / August 19, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that that it has completed its previously announced non-brokered private placement (the "Financing") on August 19, 2024. The Company accepted subscriptions of 7,845,000 units at a price of $0.05 per unit, for gross proceeds of $392,250. The Company paid finders fees to... Read More

VICTORIA, BC / ACCESSWIRE / August 19, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce that that it has completed its previously announced non-brokered private placement (the "Financing") on August 19, 2024. The Company accepted subscriptions of 7,845,000 units at a price of $0.05 per unit, for gross proceeds of $392,250. The Company paid finders fees to... Read More

VICTORIA, BC / ACCESSWIRE / August 15, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announced that it has entered into a Debt Settlement and Security Agreement with ThreeD Capital Inc. (the "Creditor") of Toronto, Ontario for payment of indebtedness owing to the Creditor in the aggregate total of $47,460 with respect to services rendered by the Creditor (the "Shares for Debt... Read More

VICTORIA, BC / ACCESSWIRE / August 9, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce that that it intends to complete a non-brokered private placement offering of up to 6,000,000 units ("Units") at a price of $0.05 per Unit for gross proceeds of up to $300,000 (the "Private Placement"). Each Unit is comprised of one Common Share and one Warrant which will... Read More

VICTORIA, BC / ACCESSWIRE / July 17, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that that it has completed its previously announced non-brokered private placement (the "Financing") on July 17, 2024. The Company accepted subscriptions on this final tranche of 10,230,000 units at a price of $0.05 per unit, for gross procees of $511,500. The Company paid... Read More

VICTORIA, BC / ACCESSWIRE / July 9, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading innovator in Artificial Intelligence and Machine Learning solutions, is pleased to announce an upcoming live webinar event. The webinar is scheduled for July 11 th at 9:00 AM PT / 12:00 PM ET and will be broadcast online. This event will feature Paul Duffy, Chief Executive Officer of... Read More

AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE - AIML; OTCQB - AIMLF; FWB - 42FB) is pleased to announce that that it has completed a first closing of its previously announced non-brokered private placement offering of up to $850,000. The Company accepted subscriptions for 9,200,000 units at a price of $0.05 per Unit for gross proceeds of $460,000. Each Unit is comprised of one Common Share and one Warrant which will... Read More

VICTORIA, BC / ACCESSWIRE / June 21, 2024 / AI/ML Innovations Inc . ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF)(FWB:42FB) is pleased to announce that that it intends to complete a non-brokered private placement offering of up to 16,500,000 units ("Units") at a price of $0.05 per Unit for gross proceeds of up to $850,000 (the "Private Placement"). Each Unit is comprised of one Common Share and one Warrant which will... Read More

VICTORIA, BC / ACCESSWIRE / June 19, 2024 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that NeuralCloud Solutions Inc., AI/ML's newest wholly owned, operating subsidiary focused on pioneering advancements at the... Read More

AI-driven Strategic Assets: Acquired Assets Include Advanced Neural Net Healthcare Technologies. VICTORIA, BC / ACCESSWIRE / June 17, 2024 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce the completion and signing of a... Read More

Highlights: Convenience: The Neural Net Store is a commercial portal offering access to AIML's suite of healthcare applications. Flexibility: AIML's healthcare tools are accessible as both APIs and cloud-based services. Unlock Value with Micropayments: Monetize each Neural Net use with a simple click. VICTORIA, BC / ACCESSWIRE / May 28, 2024 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF)... Read More

TORONTO, ON / ACCESSWIRE / May 17, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is pleased to announce that it has entered into an independent contractor agreement (the "Agreement") with Moonshot Inc. (the "Contractor") to set out the terms and conditions of the Contactor's ongoing services to be provided to the Company (the "Services"). The Services will generally consist of... Read More

Highlights: The formation of NeuralCloud Solutions Incorporated: AIML's newest division - a wholly owned, operating subsidiary focused on pioneering advancements at the convergence of the global smart sensor market and the digital health industry. The monetization of acquired assets: NeuralCloud's mandate is to advance and monetize AIML's recently acquired assets from Naiad Labs Inc. VICTORIA, BC / ACCESSWIRE / May 16, 2024... Read More

Highlights: 100 million+ ECGs are performed annually in the USA. AIML's proprietary "Long ECG Neural Net" reduces labeling of long ECGs from several days to under 5 minutes. Provides unsurpassed accuracy, depth and insight into the cardiac data. VICTORIA, BC / ACCESSWIRE / May 6, 2024 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing... Read More

Highlights: Strategic Expansion and Market Growth: AI/ML Innovations Inc. expands its portfolio by acquiring Naiad Labs Inc. Product Division. AI-driven Strategic Healthcare Assets: The purchase includes a proprietary "Long ECG Neural Net", reducing the reading and labeling of long ECGs from a couple of weeks to under 5 minutes. VICTORIA, BC / ACCESSWIRE / May 2, 2024 / AI/ML Innovations Inc. ("AIML" or the "Company")... Read More

VICTORIA, BC / ACCESSWIRE / April 10, 2024 / AI/ML Innovations Inc. (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is proud to announce the launch of its innovative "Follow Your Heart" brand, featuring Micro Payment integration by TodaQ MicroPay. As part of this unique initiative, AI/ML's... Read More

VICTORIA, BC / ACCESSWIRE / April 4, 2024 / AI/ML Innovations Inc., ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) a leading innovator in Artificial Intelligence and Machine Learning solutions, is excited to announce a live townhall event scheduled for April 7 th , 4:00 PM PST/7:00 PM EST. The event, to be broadcasted online, will feature Paul Duffy, the Chief Executive Officer of AI/ML Innovations Inc. With... Read More

Highlights: The Pulse Guru: A smart sensor wearable that redefines access to signal data for vital cardiovascular insights. Designed for healthcare innovators, researchers, and others in need of essential "raw" signal capture. The Pulse Guru's continuous stream of rich time-series data is not accessible from mainstream smartwatches such as Apple, Google, Garmin, or Fitbit. VICTORIA, BC / ACCESSWIRE / March 13, 2024 / AI/ML... Read More

TORONTO, ON / ACCESSWIRE / March 11, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FRA:42FB) announced that it has entered into a Debt Settlement and Security Agreement with ThreeD Capital Inc. (the "Creditor") of Toronto, Ontario for payment of indebtedness owing to the Creditor in the aggregate total of $27,120 with respect to services rendered by the Creditor (the "Shares for Debt... Read More

Highlights: Pioneering Precision: "Follow Your Heart" Integrates Health Gauge's Revolutionary EdgeAI and AI PrecisionPulse Neural Network Measurement Technology to produce a consumer wellness smartwatch solution with medical grade accuracy for blood pressure measurements. VICTORIA, BC / ACCESSWIRE / March 6, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to... Read More

VICTORIA, BC / ACCESSWIRE / March 4, 2024 / AI/ML Innovations Inc. (the "Company" or "AIML") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce the addition of Esmat Naikyar (BSc, Chemical Engineering) as Interim Chief Product Officer to the dynamic team at AIML. Esmat's... Read More

Highlights: FDA 510(k) Class II (Software as a Medical Device) certification commences for the Company's proprietary Blood Pressure Measurement Neural Network. The first product release to include the Company's Neural Network is "Follow Your Heart", a consumer wellness wearable smartwatch solution with medical grade accuracy . VICTORIA, BC / ACCESSWIRE / February 27, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)... Read More

Highlights: Dr. David Cramb, a distinguished academic leader, will play a pivotal role in guiding AI/ML Innovations Inc.'s scientific vision. The Science and Product Advisory Board is tasked with fostering excellence in the advancement of the science underpinning the Company's investments, developments, and operations in the health tech sector by contributing impactful guidance that ensures the integration of the latest... Read More

VICTORIA, BC / ACCESSWIRE / February 8, 2024 / AI/ML Innovations Inc. (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, presents a fireside chat with Paul Duffy, CEO of AI/ML Innovations Inc., and Hassan Kham, Co-Founder and CEO of TODAQ, where they discuss major company progress with MicroPay... Read More

Highlights: Affordable and convenient healthcare access through the potential of micropayments Simplifying healthcare transactions with a new standard for seamlessness and security VICTORIA, BC / ACCESSWIRE / February 6, 2024 / AI/ML Innovations Inc. (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal... Read More

The "Electronic Patient Reported Biometric Measures" Project, utilizes AI/ML Innovations' "The Pulse Whisperer" Patented Technology Trial participant recruitment underway VICTORIA, BC / ACCESSWIRE / January 30, 2024 / AI/ML Innovations Inc. (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs,... Read More

Highlights: Smart Sensor Wearables Redefining Data Capture and Analysis Proprietary & Patented Neural Network Technology Allowing Life Sciences Researchers to harness rich, previously inaccessible data VICTORIA, BC / ACCESSWIRE / January 23, 2024 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address... Read More

Highlights: Cornerstone Physiotherapy to provide patients with Canada's first remote Program for Long Covid Rehabilitation Impacting Remote Healthcare with Health Gauge's Scalable Biometrics Platform for Life Sciences TORONTO, ON / ACCESSWIRE / January 17, 2024 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning... Read More

TORONTO, ON / ACCESSWIRE / January 12, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announced that it has entered into an agreement for payment of indebtedness in the aggregate total of USD $55,000 (CDN $73,523.72) with Octagon Media Inc. of Las Vegas, Nevada (the "Shares for Debt Transaction") through conversion of such debt into common shares of the Corporation (the "Common Shares").... Read More

TORONTO, ON / ACCESSWIRE / January 9, 2024 / AI/ML Innovations Inc. , ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) a leading innovator in Artificial Intelligence and Machine Learning solutions, is excited to announce a live townhall event scheduled for January 11th, 7:00 PM EST. The event, to be broadcasted online, will feature Paul Duffy, the Chief Executive Officer of AI/ML Innovations Inc. The meeting will... Read More

TORONTO, ON / ACCESSWIRE / December 18, 2023 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it has closed its previously announced (December 7, 2023) arms-length non-brokered private placement financing of $754,599.94. The Company issued units at a price of $0.06 per unit, with each unit consisting of one common share and one common share warrant ("Warrant").... Read More

TORONTO, ON / ACCESSWIRE / December 11, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announces that the Marketing Services Agreement announced on September 29, 2023 with Octagon Media Corp and Jack Marks has been terminated for cause. Paul Duffy, CEO of AI/ML... Read More

TORONTO, ON / ACCESSWIRE / December 8, 2023 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that it has appointed Follow The Money Investment Group ("FTMIG") as a marketing consultant. FTMIG is a marketing group... Read More

TORONTO, ON / ACCESSWIRE / December 7, 2023 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML);(OTCQB:AIMLF);(FWB:42FB) is pleased to announce that it intends to close a non-brokered private placement on December 14th, 2023. The Company accepted subscriptions for 11,576,666 units at a price of $0.06 per unit for gross proceeds of $694,599.94 (the " Financing ") Pursuant to the terms of the Financing, each unit... Read More

TORONTO, ON / ACCESSWIRE / December 1, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announces that it has issued a total of 1,400,000 stock options pursuant to its incentive stock option plan (the "Plan") to members of management and consultants. Each option... Read More

TORONTO, ON / ACCESSWIRE / November 21, 2023 / AI/ML Innovations Inc . (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to report the results of its Annual General Meeting held on November 17, 2023. A total of 13,283,644 common shares were voted by Proxy, representing 21.1% of the... Read More

Highlights: AI/ML Innovations' minority-owned subsidiary, Tech2heal, chosen to partner with a leading French company in virtual occupational health clinics. Tech2heal's AI-driven healthcare platform forms the technological backbone of the service. TORONTO, ON / ACCESSWIRE / November 9, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial... Read More

Highlights: AI/ML Innovations Inc. is driving the next wave of AI AR Technologies with Multi-Billion Global Partners, CEO Paul Duffy Shares Vision of Transformative Healthcare Technologies Transforming the Future of Eyewear with EssilorLuxottica Deal and Partnering with a $78 Billion Eyewear Giant for Boundless Opportunities From Capture, Analyze to Action: AI/ML's Cohesive Framework for Healthcare Innovation with AI, ML and... Read More

Highlights: AI/ML Innovations' minority-owned subsidiary, Tech2heal, joins a consortium led by Essilor International (a division of EssilorLuxottica - the largest player in the global eyewear market). The focal point of the consortium is the development of a groundbreaking Augmented Reality Eyewear platform, to cater to a broad spectrum of users, transcending across professional, leisure, and daily life contexts. Tech2heal... Read More

Highlights: AI/ML's subsidiary, Tech2heal, expands its global footprint with second clinical trial contract - conducted jointly by French and Italian University Hospitals. The clinical trial is funded by a European Commission fund. The study includes a cohort of 1500 volunteer patients in remote areas with limited access to health care. The trial is focused on general preventative care of chronic diseases, and a specific... Read More

TORONTO, ON / ACCESSWIRE / October 11, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announced that it has entered into a Debt Settlement Agreement with Tormin Resources Limited of Roslin, Ontario (the "Creditor"). The Company owes the Creditor an... Read More

Highlights: The clinical study, led by the University Hospital of Nice, France involves 30,000 patients. AI/ML Innovations' subsidiary, Tech2Heal, has been chosen to provide the "technological backbone" for the study. Tech2heal has been awarded a funding grant of Euro50,000 in conjunction with this study. TORONTO, ON / ACCESSWIRE / October 4, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a... Read More

TORONTO, ON / ACCESSWIRE / September 29, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that the Company has entered into a Marketing Services Agreement dated September 22, 2023 (the "Agreement") with Octagon Media Corp. ("Octagon"), whereby Octagon will attend to meeting with management, dissemination of AIML press releases and/or AIML-generated and approved analysis,... Read More

TORONTO, ON / ACCESSWIRE / September 21, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce the addition of Mr. Fabrice Pakin, Masters (Marketing & International Business), to the Board of Directors of AI/ML Innovations Inc.... Read More

Highlights: Driving Innovation in AI and ML: Paul Duffy joins AI/ML Innovations Inc. to spearhead innovation in the dynamic fields of artificial intelligence (AI) and machine learning (ML). His leadership will be instrumental in propelling the company's mission to harness the power of AI and ML for the betterment of healthcare and other high growth domains. Visionary CEO: Duffy's appointment as CEO signifies the company's... Read More

TORONTO, ON / ACCESSWIRE / August 18, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, reports that it has issued a total of 450,000 options pursuant to its incentive stock option plan ("Plan") to management and consultants. Each option entitles the... Read More

Highlights: Digital Health Subsidiary, Tech2Heal SAS, Reports Multiple Contracts and Pilot Studies Signed Since January Launch Increasing Traction Achieved in Europe and South America in Multiple Healthcare Verticals TORONTO, ON / ACCESSWIRE / August 3, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies... Read More

TORONTO, ON / ACCESSWIRE / July 31, 2023 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that the Company has entered into a Marketing Services Agreement dated July 20, 2023 (the "Agreement") with Octagon Media Corp. ("Octagon"), whereby Octagon will attend to meeting with management, dissemination of AIML press releases and/or AIML-generated and approved analysis,... Read More

TORONTO, ON / ACCESSWIRE / July 12, 2023 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it has closed an oversubscribed non-brokered private placement announced on July 7, 2023. The Company accepted subscriptions for 3,114,087 units at a price of $0.11 per unit, for gross proceeds of $342,549.57. Each unit consists of one common share and one common share... Read More

TORONTO, ON / ACCESSWIRE / July 12, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to report that its minority-owned subsidiary, Tech2Heal SAS, has made significant advancements in its Digital Health Delivery Platform, Alakin, through the integration of... Read More

TORONTO, ON / ACCESSWIRE / July 7, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce a private placement of $364,549.57 and that it will close this non-brokered private placement on July 12, 2023. The Company has raised proceeds on the financing of... Read More

TORONTO, ON / ACCESSWIRE / June 30, 2023 / AI/ML Innovations Inc. (CSE:AIML); (OTCQB:AIMLF); (FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announces it will close the second tranche of its private placement of $1,051,200 on July 5, 2023. The Company has raised second tranche proceeds on the financing of $810,884.40 through... Read More

TORONTO, ON / ACCESSWIRE / June 16, 2023 / AI/ML Innovations Inc. (CSE - AIML); (OTCQB - AIMLF); (FWB - 42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that it intends to complete a non-brokered private placement offering of up to 3,000,000 units ("Units") at a price of $0.11 per Unit for gross proceeds of... Read More

Highlights: AI/ML Innovations Inc. wholly owned subsidiary, Health Gauge's AI-based Wearable Device (the Phoenix) was chosen to aggregate electronic patient-reported biometric measures (ePReBMs) in patients with respiratory diseases. This pilot project aims to test the feasibility and establish a multidimensional architecture for the long-term monitoring of patients with respiratory diseases, using the Health Gauge AI-based... Read More

TORONTO, ON / ACCESSWIRE / June 13, 2023 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announces the closing of its first tranche of its previously announced (June 6, 2023) private placement of $1,051,200. The Company raised first tranche proceeds on... Read More

TORONTO, ON / ACCESSWIRE / June 7, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce a private placement of $1,051,200 and that it will close the first tranche of this non-brokered private placement on June 8, 2023. The Company has raised first tranche... Read More

Agreement Highlights include: World Weight Loss ("WWL") to purchase a Private Placement of up to $750,000 WWL to purchase up to 3,000 Phoenix smart watches from Health Gauge Inc. Health Gauge Inc. to receive 1.2 million shares of WWL TORONTO, ON / ACCESSWIRE / May 26, 2023 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial... Read More

TORONTO, ON / ACCESSWORE / April 28, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, reports that it has named Tim Daniels as its interim Chief Financial Officer while the Company undertakes a search for a new Chief Financial Officer to assist with its next... Read More

Health Coach has functionality similar to ChatGPT, but is designed to monitor and manage the users health. Health Coach provides conversational personal health goal setting and care recommendations by directly accessing and utilizing a user's health data. A full service, subscription version of Health Coach is planned for this year. TORONTO, ON / ACCESSWIRE / April 11, 2023 / AI/ML Innovations Inc.... Read More

The Study, Led by the University Hospital of Nice, France Involves 30,000 Patients Tech2Heal's Platform has been chosen as the technological backbone for the Study 3.4million Europeans live in assisted-care facilities, and 101million are 65 or older TORONTO, ON / ACCESSWIRE / March 28, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial... Read More

TORONTO, ON / ACCESSWIRE / March 22, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, reports that it has engaged Frontier Flex Marketing Group ("Frontier") in a marketing services agreement to facilitate media campaigns. Specifically, Frontier will provide... Read More

TORONTO, ON / ACCESSWIRE / March 15, 2023 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) is providing an update to its previous announcement on the closing a non-brokered private placement. The Company advises that it accepted subscriptions for 4,867,748 units at a price of $0.06 per unit, not 5,086,498 units as previously announced. The gross proceeds totaled $292,064.88. For more... Read More

TORONTO, ON / ACCESSWIRE / March 14, 2023 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML); (OTCQB:AIMLF); (FWB:42FB) is pleased to announce that it has closed a non-brokered private placement. The Company accepted subscriptions for 5,086,498 units at a price of $0.06 per unit, for gross proceeds of $305,190.04. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles... Read More

TORONTO, ON / ACCESSWIRE / March 6, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to report that its wholly owned subsidiary, Health Gauge Inc., has successfully completed a blood pressure validation study utilizing its best-in-class, wearable health monitoring... Read More

TORONTO, ON / ACCESSWIRE / February 2, 2023 / AI/ML Innovations Inc. ("AIML") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, has been awarded the "2023 Innovation Grand Prize" at the prestigious L'Encéphale Medical Congress in... Read More

TORONTO, ON / ACCESSWIRE / January 23, 2023 / AI/ML Innovations Inc. (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its wholly owned subsidiary, Health Gauge Inc., has entered into a Letter of Intent with the Silicon Valley-based TaqTik Health, Inc to pilot an AI-enhanced... Read More

TORONTO, ON / ACCESSWIRE / January 12, 2023 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML); (OTCQB:AIMLF);(FWB:42FB) is pleased to announce the closing of its previously announced (December 16, 2022) warrant exercise incentive program (the "Program") intended to encourage the exercise of up to 5,648,000 unlisted common share purchase warrants of the Company (the "Eligible Warrants") exercisable for one common... Read More

TORONTO, ON / ACCESSWIRE / January 12, 2023 / AI/ML Innovations Inc. ("AIML") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, has now launched its Alakin ARPC (Automatic Remote Patient Care) Platform. Alakin is a... Read More

TORONTO, ON / ACCESSWIRE / January 4, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announces that its wholly owned subsidiary, Health Gauge Inc., is investigating the possibility of enforcement action regarding its patent rights for its personal health monitoring... Read More

TORONTO, ON / ACCESSWIRE / December 30, 2022 / AI/ML Innovations Inc. (the "Company") (CSE-AIML)(OTCQB-AIMLF)(FWB-42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that it has engaged Octagon Media Corp in a marketing services agreement to assist with a digital media campaign. Specifically, Wall Street... Read More

TORONTO, ON / ACCESSWIRE / December 16, 2022 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the implementation of a warrant exercise incentive program (the "Program") intended to encourage the exercise of up to 5,648,000 unlisted common share purchase warrants of the Company (the "Eligible Warrants") which were issued as part of the Company's private placements.... Read More

TORONTO, ON / ACCESSWIRE / November 14, 2022 / AI/ML Innovations Inc. ("AIML") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that it has entered into an Agreement to Purchase Shares (the "Agreement") with Health Gauge Inc. ("HGI"), a private technology company operating in the... Read More

AI/ML Innovations Inc. (" AI/ML " or the " Company ") (CSE:AIML; OTCQB:AIMLF; FWB:42FB) is pleased to announce that the Company's principal regulator, the British Columbia Securities Commission (" BCSC ") has lifted the Management Cease Trade Order (" MCTO ") it had previously granted the Company on August 30, 2022 under National Policy 12-203 Management Cease Trade Orders (" NP 12-203 "), as the Company has now successfully... Read More

AI/ML Innovations Inc. (" AI/ML " or the " Company ") (CSE :AIML)(OTCQB:AIMLF)(FWB:42FB) announces that further to its news releases dated August 19, 2022, August 30, 2022, September 13, 2022, September 27, 2022 and October 11, 2022, the Company's principal regulator, the British Columbia Securities Commission (the " BCSC ") granted a management cease trade order (the " MCTO ") on August 30, 2022, under National Policy... Read More

AI/ML Innovations Inc. (" AI/ML " or the " Company ") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB) announces that further to its news releases dated August 19, 2022, August 30, 2022, September 13, 2022 and September 27, 2022, the Company's principal regulator, the British Columbia Securities Commission (the " BCSC ") granted a management cease trade order (the " MCTO ") on August 30, 2022, under National Policy 12-203 Management... Read More

AI/ML Innovations Inc. (" AI/ML " or the " Company ") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that further to its news releases dated August 19, 2022, August 30, 2022 and September 13, 2022, the Company's principal regulator, the British Columbia Securities Commission (the " BCSC ") granted a management cease trade order (the " MCTO ") on August 30, 2022, under National Policy 12-203 Management Cease Trade Orders (" NP... Read More

AI/ML Innovations Inc. ( "AI/ML" or the "Company" ) (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that further to its news releases dated August 19, 2022 and August 30, 2022, the Company's principal regulator, the British Columbia Securities Commission (the "BCSC" ) granted a management cease trade order (the "MCTO" ) on August 30, 2022, under National Policy 12-203 Management Cease Trade Orders ( "NP 12-203" ). Pursuant to... Read More

AI/ML Innovations Inc. (the " Company ") (CSE:AIML; OTCQB:AIMLF; FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, did not file its audited annual financial statements, management's discussion and analysis and related CEO and CFO certifications for the financial year ended April 30, 2022 (the " Required Filings ") by the filing... Read More

AI/ML Innovations Inc. (the " Company ") (CSE:AIML; OTCQB: AIMLF; FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announces that it has made an application to the British Columbia Securities Commission (" BCSC ") to approve a management case trade order (" MCTO ") under National Policy 12-203 Management Cease Trade Orders ("... Read More

Alakin to be utilized in a Parkinson study set to commence in Paris, France AI/ML Innovations Inc. (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, has reported a second pilot study for its Alakin HEALTH care MA nagement P... Read More

All Resolutions Approved AI/ML Innovations Inc. (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announces the results of its Annual General Meeting held on July 27, 2022. A total of 5,412,712 common shares were voted by Proxy, representing 15.5% of the Company's issued and outstanding common shares,... Read More

Pre-commercial pilot study set to commence in 30,000-patient primary care facility in Paris AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, has reported that it is readying the release of "Alakin". Alakin is... Read More

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, reports that it is launching an independent clinical study to evaluate the effectiveness of its depression and anxiety therapy platform, Qookka. The study is... Read More

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, has reported that it is undertaking the certification of its products and services in accordance with the internationally agreed standard for medical devices:... Read More

AI/ML Innovations Inc. (CSE:AIML); (OTCQB:AIMLF); (FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, reports that it has been chosen as a finalist in the highly competitive "i-Nov Innovation Contest" based on its Qookka digital therapy for depressive and... Read More

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that it has engaged Octagon Media Corp in a marketing services agreement to assist with a digital media campaign. Specially, Wall Street Reporter will provide coverage of AI/ML Innovations' news releases and... Read More

MedWatch™ to address needs in the $327 billion-dollar US diabetes market License includes annual payment to Health Gauge of US$120,000, 2% gross sales royalty, US$2Million termination fee, and other royalties and fees AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to... Read More

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that it has completed a non-brokered private placement offering (the "Offering") to identified strategic health technology investors of 4,000,000 units ("Units") at $0.15 per Unit for gross proceeds of... Read More

AI/ML Innovations Inc. (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, has been chosen as one of a small and select group of candidates, to be a founding participant in the PariSanté Health Tech Campus, located in Paris, France.... Read More

Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK livestream investor conferences, and investor “LiveChats” on social media streams. Over 170,000 investors have participated in Wall Street Reporter’s livestream events in the past 90 days. Wall Street Reporter highlights companies... Read More

Highlights: First SaaS licensing contract for Health Gauge's technology Health Gauge to receive up to $2.50 per completed test Health Gauge grants exclusive licensing rights for 5 countries, provided a 50,000 test per country per month minimum is achieved by March 1, 2022 Deployment expected within 30 days AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB), a company committed to acquiring and advancing Artificial... Read More

AI/ML Innovations Inc. (CSE:AIML; OTCQB:AIMLF; FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its previously announced Warrant Early Exercise Incentive Program (the "Program") has been successfully completed. As the result of the Program, 2,288,000 warrants were exercised resulting in the issuance... Read More

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its majority-owned subsidiary, AI Rx Inc, is preparing for deployment of the Tech2Heal portfolio of products into the US marketplace. Tech2Heal is AIML's minority-owned subsidiary with a basket of wellness... Read More